The Fed­er­al Trade Com­mis­sion has sued Hims & Hers, al­leg­ing the tele­health com­pa­ny in­ap­pro­pri­ate­ly shared users’ health in­for­ma­tion with ad­ver­tis­ers and en­gaged in de­cep­tive billing...

The FDA and Capri­cor Ther­a­peu­tics of­fered sharply op­posed in­ter­pre­ta­tions of clin­i­cal da­ta back­ing the com­pa­ny's po­ten­tial new cell ther­a­py for the rare and fa­tal Duchenne...

Te­va is bet­ting it has enough room to ad­e­quate­ly pre­pare for steep tar­iffs the Trump ad­min­is­tra­tion plans to slap on gener­ic drugs made out­side the...

The US has fol­lowed through on its $600 mil­lion fund­ing com­mit­ment to Gavi, a glob­al vac­cine con­sor­tium, af­ter the funds were held in lim­bo for...

Neil Vasan, act­ing chair of the FDA's On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee, told End­points Newsthat he's stepped down from the com­mit­tee. He's par­tic­i­pat­ed in 22...